Abstract
The killing of microorganisms by neutrophils causes degranulation of azurophilic, specific, and gelatinase granules into the formed phagolysosomes. During the degranulation process, increased surface expression of CD63 (localized in the azurophilic granules of resting neutrophils) and CD66b/CD67 (from specific granules) can be detected. This results from the fusion of the granule membrane, containing these markers, with a plasma membrane. Release of granule content into the phagolysosomes or the extracellular environment occurs not only upon proper cell activation but also upon tissue injury. We compared expression of degranulation markers on neutrophils from chronic granulomatous disease (CGD) patients and healthy volunteers. Surface expression of CD63 in non-stimulated and phorbol 12-myristate 13-acetate (PMA)-stimulated neutrophils, bactericidal activity of serum, and alpha-defensins level (HNP 1–3) in plasma of CGD patients were significantly higher in comparison with healthy volunteers. At the same time, the levels of intracellular HNP 1–3 in CGD neutrophils were lower than in normal neutrophils. Thus, our data revealed augmented degranulation of azurophilic neutrophil granules in CGD, which might play a role in tissue destruction observed in this disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gallin, J.I. (1985) Neutrophil specific granule deficiency. Ann. Rev. Med. 36, 263–274.
Ganz, T. (1987) Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect. Immunol. 55, 568–571.
Lehrer, R., Lichtenstein, A. and Ganz, T. (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Ann. Rev. Immunol. 11, 105–128.
Lichtenstein, A. (1991) Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. J. Clin. Invest. 88, 93–100.
Mullmann, T.J., Cheewatrakoolpong, B., Anthes, J.C., Siegel, M.I., Egan, R.W. and Billah, M.M. (1993) Phospholipase C and phospholipase D are activated independently of each other in chemotactic peptide-stimulated human neutrophils. J. Leukoc. Biol. 53, 630–635.
Murphy P.M. (1994) The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593–633.
Nieissen, W.M. and Verhoeven A.J. (1992) Differential up-regulation of specific and azurophilic granule membrane markers in electropermeabilized neutrophils. Cell. Signal. 4, 501–509.
Orkin, S.H. (1989) Molecular genetics of chronic granulomatous disease. Ann. Rev. Immunol. 7, 207–307.
Porter, C.D., Parkar, M.G., Collins, M.K., Levinsky R.J. and Kinnon C. (1992) Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays. J. Immunol. Methods 155, 151–157.
Rice, W.G., Ganz, T., Kinkade, J.M., Selsted, M.E., Lehrer R.I. and Parmley R.T. (1987) Defensin-rich dense granules of human neutrophils. Blood 70, 757–765.
Selvatici, R., Mollica, A., Falzarano S., Spisani S. (2006) Signal transduction pathways triggered by selective formylpeptideanalogues in human neutrophils. Eur. J. Pharm. 534, 1–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Pak, V., Budikhina, A., Pashenkov, M., Pinegin, B. (2007). Neutrophil Activity in Chronic Granulomatous Disease. In: Shurin, M.R., Smolkin, Y.S. (eds) Immune-Mediated Diseases. Advances in Experimental Medicine and Biology, vol 601. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72005-0_7
Download citation
DOI: https://doi.org/10.1007/978-0-387-72005-0_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72004-3
Online ISBN: 978-0-387-72005-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)